Search

Search Results
Results 5561 - 5570 of 5578 for addiction
  • Coversyl Plus
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Coversyl Plus (perindopril and indapamide) intended for persons living in Australia.
  • Perindo Combi
    Drug - 6 Jul 2022
    Consumer Medicine Information (CMI) about Perindo Combi (perindopril and indapamide) intended for persons living in Australia.
  • Dificid
    Drug - 22 Jun 2022
    Consumer Medicine Information (CMI) about Dificid intended for persons living in Australia.
  • Imrest
    Drug - 21 Jun 2022
    Consumer Medicine Information (CMI) about Imrest intended for persons living in Australia.
  • Dapa-Tabs
    Drug - 11 May 2022
    Consumer Medicine Information (CMI) about Dapa-Tabs (indapamide hemihydrate) intended for persons living in Australia.
  • Integrilin
    Drug - 18 Mar 2022
    Consumer Medicine Information (CMI) about Integrilin intended for persons living in Australia.
  • Mersyndol Forte
    Drug - 1 Dec 2021
    Consumer Medicine Information (CMI) about Mersyndol Forte intended for persons living in Australia.
  • Lomotil
    Drug - 1 Dec 2021
    Consumer Medicine Information (CMI) about Lomotil intended for persons living in Australia.
  • Lofenoxal
    Drug - 1 Dec 2021
    Consumer Medicine Information (CMI) about Lofenoxal intended for persons living in Australia.
  • DBL Diazepam
    Drug - 29 Nov 2021
    Consumer Medicine Information (CMI) about DBL Diazepam intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback